Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Mar 8;25(1):175.
doi: 10.1186/s12887-024-05366-x.

Immune response and associated factors to Hepatitis B vaccination among children under five attending care at mulago hospital

Andrew Kimera  1 , Joseph Rujumba  2 , Cynthia Kuteesa Ndikuno  3 , Grace Ndeezi  2 , Nelson Mukiza  3 , Andrew Basenero #  2 , Theresa Piloya #  2 , Sabrina Bakeera-Kitaka #  2 , Rebecca Nabulya  3 , Anna Maria Nalumansi  4 , Agnes Namagembe  5 , Irene Bagala  2 , Agatha Namutosi  2 , Esther Kobel  2 , Zakia Bazaali  2 , Caroline Nansubuga  2 , Irene Kinera  2 , Hassan Sekina  2 , James Peter Kitonsa  2 , Isiah Kule  2 , Victor Musiime  2
Affiliations

Immune response and associated factors to Hepatitis B vaccination among children under five attending care at mulago hospital

Andrew Kimera et al. BMC Pediatr. .

Abstract

Background: Hepatitis B is a major global health concern, with chronic infections affecting approximately 296 million people yearly. A 2009 survey in East Africa showed a prevalence rate of 6.5%, with Uganda's rate at 10.3% and Northern Uganda at 20.7%. Therefore, this study sought to determine the immune response to Hepatitis B vaccination and associated factors among children under five attending outpatient care at Mulago Assessment Centre Pediatrics clinic.

Methods: A cross-sectional study involving 301 children aged 1 to under 5 years at Mulago National Referral's Pediatrics clinic was conducted in February 2023. Children were consecutively enrolled and screened for Hepatitis B core antibodies, with anti-HBs antibody titers measured. A pretested semi-structured questionnaire was administered to caregivers. Data analysis was conducted using STATA Version 13.0. Logistic regression analysis was done to determine factors associated with immune response, a binary outcome.

Results: All 301 children tested negative for Hepatitis B core antibodies. Children's ages ranged between 1 and 4 years with most aged 2 years, 89/301(29.6%). The immune response varied from 2 IU/ml to 1000 IU/ml, with a median of 86.2 IU/ml (IQR: 14.5-239.4). The prevalence of good immune response was 77.4% (233/301) (95% CI: 72.3-81.8%), with 58.4% (95% CI: 51.9-64.6%) classified as very good responders. The factors associated with immune response were child age (aOR = 0.40; 95% CI: 0.16-0.97; p = 0.044) and caregiver HIV status (aOR = 0.17; 95% CI: 0.04-0.71; p = 0.014).

Conclusion: Children had protective antibody levels against the Hepatitis B virus, but it is still below the expected level by the World Health Organization. The child's age and caregiver's HIV status were associated with immune response. Emphasis needs to be made on the Hepatitis B birth dose and booster vaccinations, especially for children over 1 year and at-risk groups, to lower transmission rates and enhance long-term Hepatitis B protection.

Keywords: Children under five years; HBs antibody; Hepatitis B vaccination; Immune response; Mulago hospital; Uganda.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical approval and consent to Participate: This study was accredited and approved by the School of Medicine Research and Ethics Committee (SOMREC) of Makerere University (Mak-SOMREC-2022-460). Permission to conduct the study was sought and obtained from the Mulago Ethics Committee and the head of MAC Pediatrics clinic, MNRH. Informed consent was obtained from all participants after clearly explaining the research objectives and procedures. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Prevalence of good immune response to Hepatitis B vaccination among children under five attending OPD care at MAC Pediatrics in MNRH
See this image and copyright information in PMC

References

    1. Hepatitis B, Facts, Figures. [https://www.hepb.org/what-is-hepatitis-b/what-is-hepb/facts-and-figures/]
    1. World Health Organisation. Hepatitis B Key facts. In.; 2021.
    1. Odusanya OO, Alufohai E, Meurice FP, Ahonkhai VI. Five-year post vaccination efficacy of hepatitis B vaccine in rural Nigeria. Hum Vaccines. 2011;7(6):625–9. - PubMed
    1. World Health Organisation: Global hepatitis report. 2017. In: Department of HIV/AIDS. 2017 edn. Geneva; 2017.
    1. World Health Organisation. Hepatitis B Fact sheeT. World Health Organisation; 2019.

Substances

LinkOut - more resources